ChemoCentryx logo
ChemoCentryx CCXI
report update icon

Quarterly report 2022-Q2
added 05-16-2026

ChemoCentryx Operating Cycle | CCXI

Annual Operating Cycle ChemoCentryx

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
43.2 0.88 11.3 226 264 1.13 K - - 23.7 77.9 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.13 K 0.88 222

Quarterly Operating Cycle ChemoCentryx

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - 29.2 26.7 9.12 0.44 6.24 1.18 2.5 2.96 0.37 2.61 1.6 1.52 2.24 12.2 11.7 2.54 5.66 252 41.8 261 522 451 564 648 986 - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
986 0.37 154

Operating Cycle of other stocks in the Biotechnology industry

Issuer Operating Cycle Price % 24h Market Cap Country
Seagen Seagen
SGEN
362 - - $ 42.2 B usaUSA
Baudax Bio Baudax Bio
BXRX
256 - 0.59 % $ 63 K usaUSA
Avid Bioservices Avid Bioservices
CDMO
148 - - $ 789 M usaUSA
Zosano Pharma Corporation Zosano Pharma Corporation
ZSAN
33.9 - 7.23 % $ 2.72 M usaUSA
Spectrum Pharmaceuticals Spectrum Pharmaceuticals
SPPI
1.17 K - - $ 189 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
1.73 - - $ 2.17 B usaUSA
Berkeley Lights Berkeley Lights
BLI
349 - -7.31 % $ 87 M usaUSA
VBI Vaccines VBI Vaccines
VBIV
1.98 - -50.87 % $ 1.09 M usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
90.1 - - $ 1.2 B usaUSA
IVERIC bio IVERIC bio
ISEE
2.41 - - $ 5.51 B usaUSA
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
21.2 - -0.04 % $ 2.62 B usaUSA
Poseida Therapeutics Poseida Therapeutics
PSTX
51 - - $ 857 M usaUSA
Y-mAbs Therapeutics Y-mAbs Therapeutics
YMAB
237 - - $ 382 M usaUSA
InMed Pharmaceuticals InMed Pharmaceuticals
INM
196 $ 15.56 13.57 % $ 64.8 M canadaCanada
SpringWorks Therapeutics SpringWorks Therapeutics
SWTX
243 - - $ 3.48 B usaUSA
Infinity Pharmaceuticals Infinity Pharmaceuticals
INFI
11.6 - -46.98 % $ 3.57 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Morphic Holding Morphic Holding
MORF
159 - - $ 2.42 B usaUSA
Genocea Biosciences Genocea Biosciences
GNCA
24.9 - -15.0 % $ 3.04 M usaUSA
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
33.6 K - -9.21 % $ 2.55 M usaUSA
Merrimack Pharmaceuticals Merrimack Pharmaceuticals
MACK
1.01 K - - $ 216 M usaUSA
Mirati Therapeutics Mirati Therapeutics
MRTX
12.7 - - $ 3.3 B usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
24.9 - -9.72 % $ 5.89 M usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
226 - 1.02 % $ 90.8 M britainBritain
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
34.8 - - $ 154 M usaUSA
Oyster Point Pharma Oyster Point Pharma
OYST
778 - - $ 300 M usaUSA
Intercept Pharmaceuticals Intercept Pharmaceuticals
ICPT
2.79 K - - $ 643 M usaUSA
Chinook Therapeutics Chinook Therapeutics
KDNY
0.93 - - $ 2.6 B usaUSA
Lumos Pharma Lumos Pharma
LUMO
13.7 - - $ 35.3 M usaUSA
Syros Pharmaceuticals Syros Pharmaceuticals
SYRS
0.05 - -8.44 % $ 3.4 M usaUSA